M Südmeyer1, L Wojtecki, A Schnitzler. Show Affiliations » 1. Neurologische Klinik - Bewegungsstörungen und Neuromodulation, Medizinische Fakultät, UKD, Düsseldorf, Germany. martin.suedmeyer@uni-duesseldorf.de
Abstract
Entities: Disease
Mesh： See more » AgedAnimalsAnti-Dyskinesia Agents/therapeutic useAntiparkinson Agents/administration & dosageAntiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useApomorphine/administration & dosageApomorphine/therapeutic useCritical CareDeep Brain StimulationDementia/etiologyDementia/therapyDepression/drug therapyDepression/etiologyDisruptive, Impulse Control, and Conduct Disorders/etiologyDisruptive, Impulse Control, and Conduct Disorders/therapyDopamine Agonists/adverse effectsDopamine Agonists/therapeutic useEurope/epidemiologyFemaleHumansInfusion Pumps, ImplantableLevodopa/administration & dosageLevodopa/adverse effectsLevodopa/therapeutic useMaleMiddle AgedMovement Disorders/etiologyMovement Disorders/therapyParkinson Disease/complicationsParkinson Disease/diagnosisParkinson Disease/drug therapyParkinson Disease/epidemiologyParkinson Disease/therapyPsychotic Disorders/etiologyPsychotic Disorders/therapySleep Wake Disorders/etiologySleep Wake Disorders/therapyTremor/drug therapyTremor/etiology
Substances： See more » Anti-Dyskinesia AgentsAntiparkinson AgentsDopamine AgonistsLevodopaApomorphine
Year: 2011 PMID： 22161168 DOI： 10.1055/s-0031-1281820
Source DB: PubMed Journal: Fortschr Neurol Psychiatr ISSN： 0720-4299 Impact factor: 0.752